Drug · DIN 02046733
PULMOZYME
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 23, 1998; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02046733
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Inhalation
- Therapeutic class (ATC)
- Dornase alfa (desoxyribonuclease) R05CB13
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DORNASE ALFA | 1 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 13, 1996: NOC 4376New Drug Submission (NDS)
- September 8, 1994: NOC 5819Supplement to a New Drug Submission (SNDS) · Change in manufacturing